Futu News, September 7: $MEDCAPTAIN (02041.HK)$Announced the allotment results: the offer price was set at HK$15.42 per share, with a total of 38.9106 million shares issued. Each lot consists of 100 shares, and the stock officially listed today.
During the public offering phase, Mindray Medical received 436.37x subscription. The final number of shares offered publicly was 3.8911 million, accounting for approximately 10% of the total shares offered. A total of approximately 57,305 valid applications were received, with about 15,492 applications accepted. The approximate percentage of allocated shares for one-lot applications relative to the total applied shares was 5%.
Additionally, during the international placement phase, Mindray Medical received 2.35x subscription. The final number of internationally placed shares was 35.0195 million, equivalent to 90% of the total shares offered. Futu has compiled the relevant data in the table below:
Company Overview
Medtronic is a global medical device provider capable of meeting clinical needs across a wide range of departments, wards, and clinics within healthcare institutions, as well as community health centers, testing facilities, and home care settings. The company's products have reached over 140 countries and regions worldwide. In China, its products have covered more than 6,000 hospitals, including approximately 90% of Grade A Tertiary Hospitals, spanning 31 provinces, municipalities, and autonomous regions.
The company has established a global business presence, with its medical device products distributed across Asia-Pacific, Europe, the Middle East and Africa, as well as the Americas...
During the public offering phase, Mindray Medical received 436.37x subscription. The final number of shares offered publicly was 3.8911 million, accounting for approximately 10% of the total shares offered. A total of approximately 57,305 valid applications were received, with about 15,492 applications accepted. The approximate percentage of allocated shares for one-lot applications relative to the total applied shares was 5%.
Additionally, during the international placement phase, Mindray Medical received 2.35x subscription. The final number of internationally placed shares was 35.0195 million, equivalent to 90% of the total shares offered. Futu has compiled the relevant data in the table below:
Company Overview
Medtronic is a global medical device provider capable of meeting clinical needs across a wide range of departments, wards, and clinics within healthcare institutions, as well as community health centers, testing facilities, and home care settings. The company's products have reached over 140 countries and regions worldwide. In China, its products have covered more than 6,000 hospitals, including approximately 90% of Grade A Tertiary Hospitals, spanning 31 provinces, municipalities, and autonomous regions.
The company has established a global business presence, with its medical device products distributed across Asia-Pacific, Europe, the Middle East and Africa, as well as the Americas...
+3
6
Hello, fellow investors! $LONGSYS (09976.HK)$ The IPO allotment results have been announced. Niu Niu New Stock has compiled the allocation data for Futu clients. Fellow investors, come check it out!![]()
![]()
LongsysAllocation details for Futu clients are as follows:
Note: No Futu clients subscribed for the maximum allotment ("top hammer"), so allocation rate data is unavailable.
Preview: Jiangbolong will conduct grey market trading on September 7 from 16:15 to 18:30, with its official listing on September 8.
$EXCELLAND ROBOT (03231.HK)$ Subscription closed. IPO allocation results will be announced on September 7.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
LongsysAllocation details for Futu clients are as follows:
Note: No Futu clients subscribed for the maximum allotment ("top hammer"), so allocation rate data is unavailable.
Preview: Jiangbolong will conduct grey market trading on September 7 from 16:15 to 18:30, with its official listing on September 8.
$EXCELLAND ROBOT (03231.HK)$ Subscription closed. IPO allocation results will be announced on September 7.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
2
3
Hello, fellow investors! $MEDCAPTAIN (02041.HK)$ The IPO allotment results have been announced. Niu Niu New Stock has compiled the allocation data for Futu clients. Fellow investors, come check it out!![]()
![]()
MedcaptainAllocation details for Futu clients are as follows:
Preview: Mindray will conduct grey market trading from 16:15 to 18:30 on September 4, with its official listing on September 7.
$LONGSYS (09976.HK)$ Subscription has closed. IPO allotment results will be announced on September 4.
$EXCELLAND ROBOT (03231.HK)$ Subscription is in full swing and will end at 10:00 on September 4.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
MedcaptainAllocation details for Futu clients are as follows:
Preview: Mindray will conduct grey market trading from 16:15 to 18:30 on September 4, with its official listing on September 7.
$LONGSYS (09976.HK)$ Subscription has closed. IPO allotment results will be announced on September 4.
$EXCELLAND ROBOT (03231.HK)$ Subscription is in full swing and will end at 10:00 on September 4.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
5
1
Futu News, September 1: $SHEIN-W (00625.HK)$ Announcement of allocation results: Priced at HK$48.56 per share, with a total issuance of 280 million shares. Each lot consists of 100 shares. Officially listed today.
During the public offering phase, SHEIN-W received 5.63x subscription. The final number of shares offered in the public tranche was 27.9993 million shares, accounting for approximately 10% of the total offer shares. A total of approximately 35,751 valid applications were received, with about 18,673 applications accepted. The approximate percentage of allocated shares for one-lot applicants relative to the total applied shares was 18.42%.
Additionally, during the international placement phase, SHEIN-W received 2.59x subscription. The final number of shares in the international tranche was 252 million shares, equivalent to 90% of the total offer shares. Futu has compiled the relevant data in the table below:
Company Overview
SHEIN is a global online fashion and lifestyle company that served approximately 273 million active customers across about 160 markets in 2025. By offering a rich variety of highly inclusive, frequently updated, and cost-effective products, the company meets diverse consumer needs and reshapes how consumers pursue fashion.
The company pioneered its proprietary operating model, "Large-scale Automated Small-order Quick Reorder" (LATR), which is the ultimate solution to the industry's long-standing trilemma. This model enables the company to balance product diversity, speed of new design launches, and...
During the public offering phase, SHEIN-W received 5.63x subscription. The final number of shares offered in the public tranche was 27.9993 million shares, accounting for approximately 10% of the total offer shares. A total of approximately 35,751 valid applications were received, with about 18,673 applications accepted. The approximate percentage of allocated shares for one-lot applicants relative to the total applied shares was 18.42%.
Additionally, during the international placement phase, SHEIN-W received 2.59x subscription. The final number of shares in the international tranche was 252 million shares, equivalent to 90% of the total offer shares. Futu has compiled the relevant data in the table below:
Company Overview
SHEIN is a global online fashion and lifestyle company that served approximately 273 million active customers across about 160 markets in 2025. By offering a rich variety of highly inclusive, frequently updated, and cost-effective products, the company meets diverse consumer needs and reshapes how consumers pursue fashion.
The company pioneered its proprietary operating model, "Large-scale Automated Small-order Quick Reorder" (LATR), which is the ultimate solution to the industry's long-standing trilemma. This model enables the company to balance product diversity, speed of new design launches, and...
+1
5
36
Futu News, September 1: $MECH-MIND ROBOT (09615.HK)$ Announced allotment results: priced at HK$101.7 per share, with a total issuance of 23.1406 million shares. Each lot consists of 30 shares, and the stock officially listed today.
During the public offering phase, Mech-Mind Robotics received subscriptions 3,835.36 times over. The final number of shares for the public offering was 4.6281 million, accounting for approximately 20% of the total offer shares. A total of approximately 252,500 valid applications were received, with about 89,100 applications accepted. The approximate percentage of allocated shares for one-lot applications relative to the total applied shares was 3%.
Additionally, during the international placement phase, Mech-Mind Robotics received subscriptions 13.39 times over. The final number of internationally placed shares was 18.5125 million, equivalent to 80% of the total offer shares. Futu has compiled the relevant data in the table below:
Company Overview
Mech-Mind Robotics is a supplier of intelligent robotics components, with its products deployed in equipment used in end customers' production and operational processes. The company's systems utilize 3D vision technology to capture point cloud data for precise spatial perception and employ AI algorithms based on deep learning. Trained on extensive industrial data, these algorithms enable autonomous recognition, decision-making, and motion planning under complex conditions such as random stacking, reflective surfaces, and partial occlusion, without relying on manual programming.
Since its establishment, the company has adhered to a globalization strategy...
During the public offering phase, Mech-Mind Robotics received subscriptions 3,835.36 times over. The final number of shares for the public offering was 4.6281 million, accounting for approximately 20% of the total offer shares. A total of approximately 252,500 valid applications were received, with about 89,100 applications accepted. The approximate percentage of allocated shares for one-lot applications relative to the total applied shares was 3%.
Additionally, during the international placement phase, Mech-Mind Robotics received subscriptions 13.39 times over. The final number of internationally placed shares was 18.5125 million, equivalent to 80% of the total offer shares. Futu has compiled the relevant data in the table below:
Company Overview
Mech-Mind Robotics is a supplier of intelligent robotics components, with its products deployed in equipment used in end customers' production and operational processes. The company's systems utilize 3D vision technology to capture point cloud data for precise spatial perception and employ AI algorithms based on deep learning. Trained on extensive industrial data, these algorithms enable autonomous recognition, decision-making, and motion planning under complex conditions such as random stacking, reflective surfaces, and partial occlusion, without relying on manual programming.
Since its establishment, the company has adhered to a globalization strategy...
+1
7
21
Hello, fellow investors!!After a lackluster August for new listings, Niu Niu's IPO expert brings you the hot IPOs for September and 2026 in Hong Kong. Fellow investors, come check them out!![]()
![]()
Only two new stocks listed in August, both related to autonomous driving concepts, $NASN TECH (02261.HK)$and chip stocks. $INGENIC (03223.HK)$ Although Nasen Technology surged over 60% on its first day of listing, it subsequently fluctuated and declined. By the close on August 31, its gains since listing had narrowed to less than 40%. While Junzheng Shares did not break its issue price, its stock price has hovered around the offering price since listing. The underwhelming performance of August's new listings has raised investor expectations for September's IPOs.
As of press time, $MEDCAPTAIN (02041.HK)$is currently open for subscription. The IPO closes at 10:00 on September 2, with grey market trading scheduled from 16:15 to 18:30 on September 4, and official listing on September 7. $LONGSYS (09976.HK)$is currently open for subscription. The IPO closes at 10:00 on September 3, with grey market trading scheduled from 16:15 to 18:30 on September 7, and official listing on September 8. $EXCELLAND ROBOT (03231.HK)$ Currently open for subscription, with the IPO closing at 10:00 on September 4. Grey market trading will take place from 16:15 to 18:30 on September 7, followed by the official listing on September 9. Additionally, $TRANSWARP TECHNOLOGY (SHANGHAI) CO., LTD. (810855.HK)$ 、 ...
Only two new stocks listed in August, both related to autonomous driving concepts, $NASN TECH (02261.HK)$and chip stocks. $INGENIC (03223.HK)$ Although Nasen Technology surged over 60% on its first day of listing, it subsequently fluctuated and declined. By the close on August 31, its gains since listing had narrowed to less than 40%. While Junzheng Shares did not break its issue price, its stock price has hovered around the offering price since listing. The underwhelming performance of August's new listings has raised investor expectations for September's IPOs.
As of press time, $MEDCAPTAIN (02041.HK)$is currently open for subscription. The IPO closes at 10:00 on September 2, with grey market trading scheduled from 16:15 to 18:30 on September 4, and official listing on September 7. $LONGSYS (09976.HK)$is currently open for subscription. The IPO closes at 10:00 on September 3, with grey market trading scheduled from 16:15 to 18:30 on September 7, and official listing on September 8. $EXCELLAND ROBOT (03231.HK)$ Currently open for subscription, with the IPO closing at 10:00 on September 4. Grey market trading will take place from 16:15 to 18:30 on September 7, followed by the official listing on September 9. Additionally, $TRANSWARP TECHNOLOGY (SHANGHAI) CO., LTD. (810855.HK)$ 、 ...
7
10
Futu News, August 31, $LONGSYS (09976.HK)$ Announcement released: The IPO subscription period is from August 31 to September 3. The company plans a global offering of approximately 26.0778 million shares and is expected to list on September 8.
Company Overview
Longsys is an independent brand semiconductor memory manufacturer. The company purchases memory wafers and controller chips from IDMs and controller chip suppliers, and does not engage in wafer fabrication. Leveraging its capabilities in controller and memory chip design, firmware development, and backend manufacturing (including system-in-package, testing, and assembly), Longsys designs, develops, manufactures via backend processes, and sells a complete portfolio of storage products for consumer, enterprise, and industrial applications.
The founding team recognized the immense potential of the global semiconductor memory market early on. Through persistent efforts and strategic development, the company expanded from trading semiconductor memory products to developing its own backend manufacturing technologies for storage products, and further evolved to build core competencies in controller and memory chip design, firmware development, and packaging and testing capabilities. This value-chain-integrated capability in semiconductor memory has enabled the company to build a portfolio of high-quality, high-performance products, earning widespread recognition from business partners and users.
Financial Overview
Longsys's total revenue increased from RMB 10,125.1 million in 2023 to RMB 17,463.7 million in 2024, and further...
Company Overview
Longsys is an independent brand semiconductor memory manufacturer. The company purchases memory wafers and controller chips from IDMs and controller chip suppliers, and does not engage in wafer fabrication. Leveraging its capabilities in controller and memory chip design, firmware development, and backend manufacturing (including system-in-package, testing, and assembly), Longsys designs, develops, manufactures via backend processes, and sells a complete portfolio of storage products for consumer, enterprise, and industrial applications.
The founding team recognized the immense potential of the global semiconductor memory market early on. Through persistent efforts and strategic development, the company expanded from trading semiconductor memory products to developing its own backend manufacturing technologies for storage products, and further evolved to build core competencies in controller and memory chip design, firmware development, and packaging and testing capabilities. This value-chain-integrated capability in semiconductor memory has enabled the company to build a portfolio of high-quality, high-performance products, earning widespread recognition from business partners and users.
Financial Overview
Longsys's total revenue increased from RMB 10,125.1 million in 2023 to RMB 17,463.7 million in 2024, and further...
+1
8
1
44
Futu News, August 31, $EXCELLAND ROBOT (03231.HK)$ announced that the IPO will take place from August 31 to September 4. The company plans a global offering of approximately 45 million shares and expects to list on September 9.
Company Overview
UDI Robotics has established a comprehensive technical framework covering vision models, robot decision-making and planning, multi-sensor fusion, localization and navigation, chassis and motion control, domain-specific robot control systems, cloud-based Vision Language Models ("VLM"), cloud data closed-loop platforms, and cloud IoT device ecosystems. These core technologies are applied through proprietary application technologies in the company's robotic products and AI vision model solutions, including cloud-based O&M, wheeled robot applications, wheel-arm robots and robotic arm applications, as well as the deployment of AI vision models in non-robotics industries.
In the field of robotics and automation, the company primarily commercializes its core and application technologies through robotic products, robotic modules, and Robotics-as-a-Service (RaaS) and leasing arrangements. Through continuous R&D and ongoing product iterations, the company has expanded its robotics product portfolio to cover various service scenarios.
Financial Overview
UDI Robotics' total revenue increased from RMB 243.8 million in FY2023 to RMB 267.1 million in FY2024, and further increased to RMB 3... in FY2025
Company Overview
UDI Robotics has established a comprehensive technical framework covering vision models, robot decision-making and planning, multi-sensor fusion, localization and navigation, chassis and motion control, domain-specific robot control systems, cloud-based Vision Language Models ("VLM"), cloud data closed-loop platforms, and cloud IoT device ecosystems. These core technologies are applied through proprietary application technologies in the company's robotic products and AI vision model solutions, including cloud-based O&M, wheeled robot applications, wheel-arm robots and robotic arm applications, as well as the deployment of AI vision models in non-robotics industries.
In the field of robotics and automation, the company primarily commercializes its core and application technologies through robotic products, robotic modules, and Robotics-as-a-Service (RaaS) and leasing arrangements. Through continuous R&D and ongoing product iterations, the company has expanded its robotics product portfolio to cover various service scenarios.
Financial Overview
UDI Robotics' total revenue increased from RMB 243.8 million in FY2023 to RMB 267.1 million in FY2024, and further increased to RMB 3... in FY2025
+1
7
23
Hello, fellow investors! $SHEIN-W (00625.HK)$ $MECH-MIND ROBOT (09615.HK)$ The allotment results have been announced! Niu Niu Xin Gu Jun has compiled the allocation details for Futu clients—fellow investors, check it out now!![]()
![]()
SHEIN-WAllocation details for Futu clients are as follows:
Mech-Mind RoboticsAllocation details for Futu clients are as follows:
Notice: The above two new stocks will undergo grey market trading from 16:15 to 18:30 on August 31, with official listing on September 1.
$MEDCAPTAIN (02041.HK)$ Subscription is currently in full swing and will close at 10:00 on September 2.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
SHEIN-WAllocation details for Futu clients are as follows:
Mech-Mind RoboticsAllocation details for Futu clients are as follows:
Notice: The above two new stocks will undergo grey market trading from 16:15 to 18:30 on August 31, with official listing on September 1.
$MEDCAPTAIN (02041.HK)$ Subscription is currently in full swing and will close at 10:00 on September 2.
The golden season for subscribing to new stocks is here! Subscribe via Futu with 0% interest, 0 fees, and 0 cash deposit required. Participate in the current promotion for a chance to waive your new stock subscription fees for 1 year,Come try it out now >>
11
1
10
Futu News, August 28, $MEDCAPTAIN (02041.HK)$ announced that the IPO will take place from August 28 to September 2. The company intends to offer approximately 38.9106 million shares globally and is expected to list on September 7.
Company Overview
Medtronic is a global medical device provider capable of meeting clinical needs across a wide range of departments, wards, and clinics within healthcare institutions, as well as community health centers, testing facilities, and home care settings. The company's products have reached over 140 countries and regions worldwide. In China, its products have covered more than 6,000 hospitals, including approximately 90% of Grade A Tertiary Hospitals, spanning 31 provinces, municipalities, and autonomous regions.
The company has established a global business presence, with its medical device products distributed across Asia-Pacific, Europe, the Middle East and Africa, and the Americas. It has strategically set up five R&D centers and six production centers in China and the UK. To enhance its international service capabilities, the company maintains local representative offices in strategic markets such as the UK, Netherlands, Belgium, Turkey, India, Thailand, Indonesia, Mexico, Brazil, and Colombia, ensuring timely and localized support for its global customer base.
Financial Overview
Medtronic's revenue increased from RMB 1,313.3 million in 2023 to RMB 1,619.2 million in 2025, and from the period ending...
Company Overview
Medtronic is a global medical device provider capable of meeting clinical needs across a wide range of departments, wards, and clinics within healthcare institutions, as well as community health centers, testing facilities, and home care settings. The company's products have reached over 140 countries and regions worldwide. In China, its products have covered more than 6,000 hospitals, including approximately 90% of Grade A Tertiary Hospitals, spanning 31 provinces, municipalities, and autonomous regions.
The company has established a global business presence, with its medical device products distributed across Asia-Pacific, Europe, the Middle East and Africa, and the Americas. It has strategically set up five R&D centers and six production centers in China and the UK. To enhance its international service capabilities, the company maintains local representative offices in strategic markets such as the UK, Netherlands, Belgium, Turkey, India, Thailand, Indonesia, Mexico, Brazil, and Colombia, ensuring timely and localized support for its global customer base.
Financial Overview
Medtronic's revenue increased from RMB 1,313.3 million in 2023 to RMB 1,619.2 million in 2025, and from the period ending...
+1
12
1
41
![[empty]](https://cdn.futustatic.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://cdn.futustatic.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)